logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Eli Lilly and Company Appoints Lucas Montarce As Executive Vice President and CFO

Sep 09, 2024•11 months ago

Position

Chief Financial Officer

Company

Eli Lilly

Lucas Montarce
IndianapolisPharmaceuticalManufacturingHealth Care

Description

Eli Lilly and Company announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company's Executive Committee, effective immediately.

Company Information

Company

Eli Lilly

Location

Indianapolis, Indiana, United States

About

Eli Lilly is a global healthcare and pharmaceutical company focused on the discovery, development, and delivery of innovative pharmaceutical medicines, vaccines, and consumer healthcare products. It has a strong presence in the diabetes and obesity market segment and has been actively expanding its manufacturing network to meet the increasing demand for its medicines.

Company News

(10 articles)
Thu, 31 Jul 2025 01:28:37 GMT

Your story matters - Eli Lilly and Company

Fri, 04 Mar 2022 16:56:02 GMT

Lilly and Lilly Foundation Provide Support for People in Ukraine - Eli Lilly and Company

Tue, 23 Jul 2024 19:12:40 GMT

Protecting the Horseshoe Crab: One Small Animal, One Big Impact | Eli Lilly and Company - Eli Lilly and Company

Thu, 17 Apr 2025 07:00:00 GMT

Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial - Eli Lilly and Company

Wed, 01 Mar 2023 13:02:27 GMT

Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month - Eli Lilly and Company

Tue, 27 Oct 2020 07:00:00 GMT

CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access - Eli Lilly and Company

Tue, 02 Jul 2024 07:00:00 GMT

Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease - Eli Lilly and Company

Wed, 15 Dec 2021 08:00:00 GMT

Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting - Eli Lilly and Company

Tue, 29 Oct 2024 07:00:00 GMT

Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study - Eli Lilly and Company

Wed, 22 May 2019 07:00:00 GMT

Lilly's Lower-Priced Insulin Now Available - Eli Lilly and Company

FundzWatch™ Score

79
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months